ORIC Oric Pharmaceuticals, Inc.

company

SEC Filings & Insider Trading Activity 2026

Risk Factors

• • New risk: Market conditions risk of banking insolvency triggered by 2023 Silicon Valley Bank receivership causing temporary funds inaccessibility
• • Most material update: Net loss $99M for nine months ended Sept 30, 2025; accumulated deficit $661.7M, reflecting ongoing significant losses

What are the latest ORIC SEC filings in 2026?

Oric Pharmaceuticals, Inc. (ORIC) has filed a 10-K annual report on February 23, 2026, a 10-Q quarterly report on November 13, 2025, an 8-K current report on March 31, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did ORIC file its most recent 10-K annual report?

Oric Pharmaceuticals, Inc. (ORIC) filed its most recent 10-K annual report on February 23, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view ORIC 10-Q quarterly reports?

Oric Pharmaceuticals, Inc. (ORIC)'s most recent 10-Q quarterly report was filed on November 13, 2025. SignalX displays every ORIC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has ORIC filed recently?

Oric Pharmaceuticals, Inc. (ORIC)'s most recent 8-K was filed on March 31, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find ORIC insider trading activity (Form 4)?

SignalX aggregates every ORIC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does ORIC file with the SEC?

Oric Pharmaceuticals, Inc. (ORIC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ORIC filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Oric Pharmaceuticals, Inc. (ORIC).

What is ORIC's SEC CIK number?

Oric Pharmaceuticals, Inc. (ORIC)'s SEC CIK (Central Index Key) number is 1796280. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1796280 to look up all ORIC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find ORIC return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Oric Pharmaceuticals, Inc. (ORIC) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.